Compare Avalon Labs (AVL) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avalon Labs vs Mira — how do they compare? Avalon Labs trades at Rp284.16 (market cap Rp45,49M, Rp17,37M 24h volume), while Mira trades at Rp698.2 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: Mira is far larger — about 4.9× Avalon Labs's market cap, and Avalon Labs's circulating supply is 161,7M / 1B AVL (17%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Avalon Labs for 9 Days and Mira for 22 Days on average.
| AVL | MIRA | |
|---|---|---|
Market Cap | Rp45,49M | Rp224,51M |
Volume (24h) | Rp17,37M | Rp102,44M |
Circulating Supply | 161,7M / 1B AVL (17%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 9 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AVL is trading at Rp286.54 with a bearish technical outlook, showing sell signals across moving averages while oscillators remain neutral. The token faces resistance at Rp288 with support at Rp280, indicating potential downside pressure. With only 17% of max supply circulating and average hold time of 9 days, liquidity remains limited. Recent news shows no direct crypto ecosystem developments for this token.
Overall outlook remains cautious with bearish technical momentum outweighing neutral oscillators. Key opportunity lies in potential breakout above Rp288 resistance, while major risks include low liquidity, limited circulation, and absence of recent protocol updates. Investors should monitor for any blockchain ecosystem developments that could drive adoption.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Avalon Labs
Avalon Labs is building an on-chain financial center for Bitcoin, offering solutions like BTC-backed lending, a Bitcoin-backed stablecoin, yield-generating accounts, and a credit card. Our goal is to create a scalable, transparent, and accessible financial network for Bitcoin holders to use Bitcoin as an economic asset. AVL is the governance token of the Avalon Labs ecosystem. We started as the world's largest issuer of Bitcoin-backed collateralized debt positions (CDPs) and have since expanded into DeFi lending, fixed-rate CeDeFi models, and stablecoins. This growth, driven by community demand, positions Avalon as a leader in on-chain finance. With AVL, we empower our community to actively shape the future of Avalon.
Read more on AVL →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
